Lennert Janssen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Lennert Janssen has a total of 187 co-authors. Here are the top co-authors by number of shared publications:
- Jacques Neefjes
Department of Cell and Chemical Biology, ONCODE Institute, Leiden University Medical Center
31 shared publications Hans Janssen
Division of Cell Biology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands
10 shared publicationsCoenraad Kuijl
6 shared publications- Huib Ovaa
Leiden University Medical Center
5 shared publications Marije Marsman
Division of Tumor Biology, and,
5 shared publications- Rik van der Kant
Center for Neurogenomics and Cognitive Research, Vrije Universiteit Amsterdam, Amsterdam Neuroscience, Amsterdam, the Netherlands
5 shared publications
Latest Publications
- Open Access
Salmonella exploits USP32 to coordinate Rab14 and Rab11 recycling pathways for intracellular survival
Many intracellular bacterial pathogens establish membrane-bound niches derived from host material to survive and replicate within host cells. These compartments are carved through subversion of host intracellular trafficking pathways to modulate the composition of the vacuolar membrane. Although recycling-associated small Rab GTPases are frequently observed at infection sites, their role in membrane remodeling and cargo sorting has remained poorly understood. Here, we leverage the extensive early membrane remodeling occurring during Salmonella infection to dissect this process. Using endogenously tagged cell lines, we characterize the dynamics of the recycling small GTPases Rab14 and Rab11 at Salmonella intracellular infection sites. We report that Rab14 recruits its effector Rufy1, which mediates sorting of CI-M6PR through recycling tubules. Subsequently, Rab11 disperses the newly formed recycling endosomes by interacting with its effector Fip3 for retrograde transport. This pathway is controlled by the deubiquitinating enzyme USP32, which targets both Rab14 and Rab11, enhancing their interactions with Rufy1 and Fip3, respectively. We further show that USP32 is recruited to the infection site via local enrichment of phosphatidylserine-positive membranes, a process triggered by the Salmonella effector proteins SopE/E2. Importantly, silencing USP32 significantly impairs intracellular bacterial survival. Our findings reveal a remarkable exploitation of host signaling and trafficking pathways by Salmonella to construct a pro-replicative niche. Targeting these pathways may offer new strategies for therapeutic intervention against intracellular bacterial infections.
Open AccessSalmonella exploits USP32 to coordinate Rab14 and Rab11 recycling pathways for intracellular survival
Many intracellular bacterial pathogens establish membrane-bound niches derived from host material to survive and replicate within host cells. These compartments are carved through subversion of host intracellular trafficking pathways to modulate the composition of the vacuolar membrane. Although recycling-associated small Rab GTPases are frequently observed at infection sites, their role in membrane remodeling and cargo sorting has remained poorly understood. Here, we leverage the extensive early membrane remodeling occurring during Salmonella infection to dissect this process. Using endogenously tagged cell lines, we characterize the dynamics of the recycling small GTPases Rab14 and Rab11 at Salmonella intracellular infection sites. We report that Rab14 recruits its effector Rufy1, which mediates sorting of CI-M6PR through recycling tubules. Subsequently, Rab11 disperses the newly formed recycling endosomes by interacting with its effector Fip3 for retrograde transport. This pathway is controlled by the deubiquitinating enzyme USP32, which targets both Rab14 and Rab11, enhancing their interactions with Rufy1 and Fip3, respectively. We further show that USP32 is recruited to the infection site via local enrichment of phosphatidylserine-positive membranes, a process triggered by the Salmonella effector proteins SopE/E2. Importantly, silencing USP32 significantly impairs intracellular bacterial survival. Our findings reveal a remarkable exploitation of host signaling and trafficking pathways by Salmonella to construct a pro-replicative niche. Targeting these pathways may offer new strategies for therapeutic intervention against intracellular bacterial infections.
- Open Access
- 29 November 2025
- Published by Elsevier in Journal of Structural Biology
- Vol. 217 (4) , 108267
Dual-colour super-resolution cryoCLEM in mammalian cells using the fluorescent proteins rsTagRFP and rsEGFP2
- 29 November 2025
- Published by Elsevier in Journal of Structural Biology
- Vol. 217 (4) , 108267
Open AccessDual-colour super-resolution cryoCLEM in mammalian cells using the fluorescent proteins rsTagRFP and rsEGFP2
- Open Access
Colon cancer and cell transformation by clinical Salmonella strains are associated with bacterial virulence and intracellular fitness
SUMMARY: Non-typhoidal Salmonella (NTS) are facultative intracellular pathogens that are associated epidemiologically and experimentally with colon cancer development. Yet, the driving factors of Salmonella -induced cell transformation are mostly unknown. We compared 30 (case) NTS clinical strains isolated from patients who were diagnosed with colon cancer >1 year after NTS infection, versus 30 (control) strains from patients who did not develop colon cancer. While we observed diverse cell invasion and transformation efficiencies among the 60 NTS strains, case strains showed higher transformation efficiency than matching control strains. Genomic and transcriptomic analyses showed that transformation efficiency could not be attributed to specific genomic features, but was associated with gene expression, particularly metabolic genes and regulons. Moreover, high-transforming NTS strains display increased capacity to utilize various nutrient sources, including carbohydrates and amino acids, and grow significantly faster intracellularly than low-transforming NTS. Our results link NTS intracellular virulence to cancer promotion. Graphical In brief: Non-typhoidal Salmonella (NTS) infections can promote cell transformation and colon cancer progression. Yet, little is known about the driving factors of Salmonella -induced transformation. Stévenin et al. performed a multi-omic characterization of clinical NTS strains identified in a nation-wide epidemiological study as associated with colon cancer and revealed a link between bacterial virulence, intracellular fitness, and host cell transformation. Highlights: - Cancer-associated clinical NTS generate more cell transformation than matching control NTS. - NTS transformation efficiency did not correlate with specific genetic features. - NTS transformation efficiency correlates with gene expression and bacterial metabolic needs. - High-transforming NTS display increased virulence and intracellular fitness.
Open AccessColon cancer and cell transformation by clinical Salmonella strains are associated with bacterial virulence and intracellular fitness
SUMMARY: Non-typhoidal Salmonella (NTS) are facultative intracellular pathogens that are associated epidemiologically and experimentally with colon cancer development. Yet, the driving factors of Salmonella -induced cell transformation are mostly unknown. We compared 30 (case) NTS clinical strains isolated from patients who were diagnosed with colon cancer >1 year after NTS infection, versus 30 (control) strains from patients who did not develop colon cancer. While we observed diverse cell invasion and transformation efficiencies among the 60 NTS strains, case strains showed higher transformation efficiency than matching control strains. Genomic and transcriptomic analyses showed that transformation efficiency could not be attributed to specific genomic features, but was associated with gene expression, particularly metabolic genes and regulons. Moreover, high-transforming NTS strains display increased capacity to utilize various nutrient sources, including carbohydrates and amino acids, and grow significantly faster intracellularly than low-transforming NTS. Our results link NTS intracellular virulence to cancer promotion. Graphical In brief: Non-typhoidal Salmonella (NTS) infections can promote cell transformation and colon cancer progression. Yet, little is known about the driving factors of Salmonella -induced transformation. Stévenin et al. performed a multi-omic characterization of clinical NTS strains identified in a nation-wide epidemiological study as associated with colon cancer and revealed a link between bacterial virulence, intracellular fitness, and host cell transformation. Highlights: - Cancer-associated clinical NTS generate more cell transformation than matching control NTS. - NTS transformation efficiency did not correlate with specific genetic features. - NTS transformation efficiency correlates with gene expression and bacterial metabolic needs. - High-transforming NTS display increased virulence and intracellular fitness.
- Open Access
The SPPL3-defined glycosphingolipid repertoire regulates immune responses by improving HLA class I access
Summary: HLA class I (HLA-I) drives immune responses by presenting antigen-derived peptides to cognate CD8 + T cells. This process is often hijacked by tumors and pathogens for immune evasion. Since therapeutic options for restoring HLA-I antigen presentation are limited, we aimed to identify new HLA-I pathway targets. By iterative genome-wide screens we uncovered that the cell surface glycosphingolipid (GSL) repertoire determines effective HLA-I antigen presentation. We show that absence of the protease SPPL3 augments B3GNT5 enzyme activity, resulting in upregulated levels of surface (neo)lacto-series GSLs. These GSLs sterically impede molecular interactions with HLA-I and diminish CD8 + T cell activation. In accordance, a disturbed SPPL3-B3GNT5 pathway in glioma associates with decreased patient survival. Importantly, we show that this immunomodulatory effect can be reversed through GSL synthesis inhibition using clinically approved drugs. Overall, our study identifies a GSL signature that functionally inhibits antigen presentation and represents a potential therapeutic target in cancer, infection and autoimmunity.
Open AccessThe SPPL3-defined glycosphingolipid repertoire regulates immune responses by improving HLA class I access
Summary: HLA class I (HLA-I) drives immune responses by presenting antigen-derived peptides to cognate CD8 + T cells. This process is often hijacked by tumors and pathogens for immune evasion. Since therapeutic options for restoring HLA-I antigen presentation are limited, we aimed to identify new HLA-I pathway targets. By iterative genome-wide screens we uncovered that the cell surface glycosphingolipid (GSL) repertoire determines effective HLA-I antigen presentation. We show that absence of the protease SPPL3 augments B3GNT5 enzyme activity, resulting in upregulated levels of surface (neo)lacto-series GSLs. These GSLs sterically impede molecular interactions with HLA-I and diminish CD8 + T cell activation. In accordance, a disturbed SPPL3-B3GNT5 pathway in glioma associates with decreased patient survival. Importantly, we show that this immunomodulatory effect can be reversed through GSL synthesis inhibition using clinically approved drugs. Overall, our study identifies a GSL signature that functionally inhibits antigen presentation and represents a potential therapeutic target in cancer, infection and autoimmunity.
- 1 January 2020
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 133 (19)
Invariant chain regulates endosomal fusion and maturation through an interaction with the SNARE Vti1b
The Invariant chain (Ii, CD74) is a multifunctional regulator of adaptive immune responses and responsible for sorting MHC-I, MHC-II and other Ii-associated molecules to a specific endosomal pathway. When Ii is expressed, endosomal maturation and proteolytic degradation of proteins are delayed and in non-antigen presenting cells the endosomal size increase, but he molecular mechanisms are not known. We identified that a SNARE, Vti1b, is essential for regulating these Ii induced effects. Vti1b binds to Ii and Vti1b is localized at the contact sites of fusing Ii positive endosomes. Furthermore, a tailless Ii that is not internalized from the plasma membrane relocates Vti1b to the plasma membrane. KO of Ii in an antigen presenting cell line was found to speed up endosomal maturation and silencing of Vti1b inhibits the Ii induced maturation delay. Our results suggest that Ii, by interacting with the SNARE Vti1b in antigen presenting cells, direct specific Ii associated SNARE mediated fusion in the early part of the endosomal pathway that lead to a slower endosomal maturation for efficient antigen processing and MHC antigen loading.
- 1 January 2020
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 133 (19)
Invariant chain regulates endosomal fusion and maturation through an interaction with the SNARE Vti1b
The Invariant chain (Ii, CD74) is a multifunctional regulator of adaptive immune responses and responsible for sorting MHC-I, MHC-II and other Ii-associated molecules to a specific endosomal pathway. When Ii is expressed, endosomal maturation and proteolytic degradation of proteins are delayed and in non-antigen presenting cells the endosomal size increase, but he molecular mechanisms are not known. We identified that a SNARE, Vti1b, is essential for regulating these Ii induced effects. Vti1b binds to Ii and Vti1b is localized at the contact sites of fusing Ii positive endosomes. Furthermore, a tailless Ii that is not internalized from the plasma membrane relocates Vti1b to the plasma membrane. KO of Ii in an antigen presenting cell line was found to speed up endosomal maturation and silencing of Vti1b inhibits the Ii induced maturation delay. Our results suggest that Ii, by interacting with the SNARE Vti1b in antigen presenting cells, direct specific Ii associated SNARE mediated fusion in the early part of the endosomal pathway that lead to a slower endosomal maturation for efficient antigen processing and MHC antigen loading.
- 15 May 2019
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 132 (10) , jcs.225524
Homeostasis of soluble proteins and the proteasome post nuclear envelope reformation in mitosis
Upon nuclear envelope (NE) fragmentation in the prometaphase, the nuclear and cytosolic proteomes mix and must be redefined to reinstate homeostasis. Here, by using a molecular GFP ladder, we show that in early mitosis, condensed chromatin excludes cytosolic proteins. When the NE reforms tightly around condensed chromatin in late mitosis, large GFP multimers are automatically excluded from the nucleus. This can be circumvented by limiting DNA condensation with Q15, a condensin II inhibitor. Soluble small and other nuclear localization sequence (NLS)-targeted proteins then swiftly enter the expanding nuclear space. We then examined proteasomes, which are located in the cytoplasm and nucleus. A significant fraction of 20S proteasomes is imported by the importin IPO5 within 20 min of reformation of the nucleus, after which import comes to an abrupt halt. This suggests that maintaining the nuclear–cytosol distribution after mitosis requires chromatin condensation to exclude cytosolic material from the nuclear space, and specialized machineries for nuclear import of large protein complexes, such as the proteasome.
- 15 May 2019
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 132 (10) , jcs.225524
Homeostasis of soluble proteins and the proteasome post nuclear envelope reformation in mitosis
Upon nuclear envelope (NE) fragmentation in the prometaphase, the nuclear and cytosolic proteomes mix and must be redefined to reinstate homeostasis. Here, by using a molecular GFP ladder, we show that in early mitosis, condensed chromatin excludes cytosolic proteins. When the NE reforms tightly around condensed chromatin in late mitosis, large GFP multimers are automatically excluded from the nucleus. This can be circumvented by limiting DNA condensation with Q15, a condensin II inhibitor. Soluble small and other nuclear localization sequence (NLS)-targeted proteins then swiftly enter the expanding nuclear space. We then examined proteasomes, which are located in the cytoplasm and nucleus. A significant fraction of 20S proteasomes is imported by the importin IPO5 within 20 min of reformation of the nucleus, after which import comes to an abrupt halt. This suggests that maintaining the nuclear–cytosol distribution after mitosis requires chromatin condensation to exclude cytosolic material from the nuclear space, and specialized machineries for nuclear import of large protein complexes, such as the proteasome.
- Open Access
- 10 June 2016
- Published by Springer Nature in Nature Communications
- Vol. 7 (1) , 11808
Cholesterol and ORP1L-mediated ER contact sites control autophagosome transport and fusion with the endocytic pathway
Autophagy is the main homeostatic pathway guiding cytosolic materials for degradation by the lysosome. Maturation of autophagosomes requires their transport towards the perinuclear region of the cell, with key factors underlying both processes still poorly understood. Here we show that transport and positioning of late autophagosomes depends on cholesterol by way of the cholesterol-sensing Rab7 effector ORP1L. ORP1L localizes to late autophagosomes and—under low-cholesterol conditions—contacts the ER protein VAP-A, forming ER-autophagosome contact sites, which prevent minus-end transport by the Rab7–RILP–dynein complex. ORP1L-mediated contact sites also inhibit localization of PLEKHM1 to Rab7. PLEKHM1, together with RILP, then recruits the homotypic fusion and vacuole protein-sorting (HOPS) complex for fusion of autophagosomes with late endosomes and lysosomes. Thus, ORP1L, via its liganding by lipids and the formation of contacts between autophagic vacuoles and the ER, governs the last steps in autophagy that lead to the lysosomal degradation of cytosolic material.
- 10 June 2016
- Published by Springer Nature in Nature Communications
- Vol. 7 (1) , 11808
Open AccessCholesterol and ORP1L-mediated ER contact sites control autophagosome transport and fusion with the endocytic pathway
Autophagy is the main homeostatic pathway guiding cytosolic materials for degradation by the lysosome. Maturation of autophagosomes requires their transport towards the perinuclear region of the cell, with key factors underlying both processes still poorly understood. Here we show that transport and positioning of late autophagosomes depends on cholesterol by way of the cholesterol-sensing Rab7 effector ORP1L. ORP1L localizes to late autophagosomes and—under low-cholesterol conditions—contacts the ER protein VAP-A, forming ER-autophagosome contact sites, which prevent minus-end transport by the Rab7–RILP–dynein complex. ORP1L-mediated contact sites also inhibit localization of PLEKHM1 to Rab7. PLEKHM1, together with RILP, then recruits the homotypic fusion and vacuole protein-sorting (HOPS) complex for fusion of autophagosomes with late endosomes and lysosomes. Thus, ORP1L, via its liganding by lipids and the formation of contacts between autophagic vacuoles and the ER, governs the last steps in autophagy that lead to the lysosomal degradation of cytosolic material.
- Open Access
- 1 December 2015
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 290 (51) , 30280-30290
Characterization of the Mammalian CORVET and HOPS Complexes and Their Modular Restructuring for Endosome Specificity
- 1 December 2015
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 290 (51) , 30280-30290
Open AccessCharacterization of the Mammalian CORVET and HOPS Complexes and Their Modular Restructuring for Endosome Specificity
- Open Access
- 1 November 2015
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 195 (9) , 4085-4095
Definition of Proteasomal Peptide Splicing Rules for High-Efficiency Spliced Peptide Presentation by MHC Class I Molecules
Peptide splicing, in which two distant parts of a protein are excised and then ligated to form a novel peptide, can generate unique MHC class I–restricted responses. Because these peptides are not genetically encoded and the rules behind proteasomal splicing are unknown, it is difficult to predict these spliced Ags. In the current study, small libraries of short peptides were used to identify amino acid sequences that affect the efficiency of this transpeptidation process. We observed that splicing does not occur at random, neither in terms of the amino acid sequences nor through random splicing of peptides from different sources. In contrast, splicing followed distinct rules that we deduced and validated both in vitro and in cells. Peptide ligation was quantified using a model peptide and demonstrated to occur with up to 30% ligation efficiency in vitro, provided that optimal structural requirements for ligation were met by both ligating partners. In addition, many splicing products could be formed from a single protein. Our splicing rules will facilitate prediction and detection of new spliced Ags to expand the peptidome presented by MHC class I Ags.
- 1 November 2015
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 195 (9) , 4085-4095
Open AccessDefinition of Proteasomal Peptide Splicing Rules for High-Efficiency Spliced Peptide Presentation by MHC Class I Molecules
Peptide splicing, in which two distant parts of a protein are excised and then ligated to form a novel peptide, can generate unique MHC class I–restricted responses. Because these peptides are not genetically encoded and the rules behind proteasomal splicing are unknown, it is difficult to predict these spliced Ags. In the current study, small libraries of short peptides were used to identify amino acid sequences that affect the efficiency of this transpeptidation process. We observed that splicing does not occur at random, neither in terms of the amino acid sequences nor through random splicing of peptides from different sources. In contrast, splicing followed distinct rules that we deduced and validated both in vitro and in cells. Peptide ligation was quantified using a model peptide and demonstrated to occur with up to 30% ligation efficiency in vitro, provided that optimal structural requirements for ligation were met by both ligating partners. In addition, many splicing products could be formed from a single protein. Our splicing rules will facilitate prediction and detection of new spliced Ags to expand the peptidome presented by MHC class I Ags.